Related Experiment Video
Updated: May 25, 2026

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis
Published on: June 2, 2015
Quality of INR control and outcomes following venous thromboembolism
Arlene M Gallagher1, Frank de Vries, Jonathan M Plumb
1General Practice Research Database, Medicines and Healthcare products Regulatory Agency, London, UK.
Insights
Maintaining therapeutic anticoagulation levels (international normalized ratio [INR]) is crucial for reducing venous thromboembolism (VTE) recurrence and mortality. Achieving over 70% time in therapeutic range significantly lowers these risks.
Area of Science:
- Medical research
- Clinical practice
- Pharmacology
Background:
- Venous thromboembolism (VTE) poses a significant health risk.
- Understanding anticoagulation patterns in real-world settings is essential.
Purpose of the Study:
- To evaluate anticoagulation management following VTE.
- To assess the impact of anticoagulation on VTE recurrence and mortality.
Main Methods:
- Utilized the General Practice Research Database.
- Matched VTE patients (18+ years) with three controls.
- Analyzed international normalized ratio (INR) control and outcomes.
Main Results:
- Mean time within therapeutic INR range was 57.0%.
- VTE recurrence was lowest in patients with ≥70% time in therapeutic range (RR 0.50).
- Higher time in therapeutic INR range correlated with reduced VTE recurrence and mortality.
Conclusions:
- Optimal anticoagulation control (≥70% time in therapeutic INR range) is associated with better patient outcomes.
- Effective INR management is key to minimizing VTE recurrence and associated deaths.
Introduction:
The objective of this study was to evaluate the pattern of anticoagulation after venous thromboembolism (VTE) in actual clinical practice.
Material And Methods:
This study used the General Practice Research Database. Individuals aged 18+ years with VTE were matched to 3 controls.
Results:
Of the 46 335 patients with VTE and 138 024 controls, 70.2% of cases and 86.6% of controls had no obvious risk factors. The mortality risk was increased substantially around the time of diagnosis (relative hazard rate [RR] around 21) but remained elevated for a further 4 years (RRs around 1.5-2.0). The mean percentage of time spent within the therapeutic range for international normalized ratio (INR) was 57.0%. The lowest rate of VTE recurrence occurred in patients with ≥70% time spent within therapeutic range (RR of 0.50, 95% CI 0.39-0.63 compared to <30%).
Conclusions:
Higher time spent within therapeutic INR range was associated with lower risks of VTE recurrence and death due to VTE.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis IV: Nursing Management
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Venous Thrombosis I: Introduction
Venous Return
What is Venous Return?
Venous return refers to the rate at which blood flows back to the heart from the body's peripheral veins. It's an integral part of the circulatory system as it...
Pulmonary Embolism III: Nursing Management
